Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSYKED-NP: Ketamine and Psychotherapy for Chronic Neuropathic Pain
NCT05639322Phase 4Completed
- Sponsor
- Unity Health Toronto
- Start
- Oct 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketamine in chronic neuropathic pain (3 arms), sponsored by Unity Health Toronto. Primary endpoints: Recruitment rate at 2 years, Adherence rate at 2 years and 1 more. Started Oct 2023; status: completed.
02
Drugs
ketamine
03
Conditions
chronic neuropathic pain
Beyond the preview
Go deeper on NCT05639322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05639322.